Click on a filter below to refine your search. Remove a filter to broaden your search.
An increase was seen during the pandemic period, following a decrease between 1950 and 2019; child mortality continued to drop during the pandemic.
A new website aims to assist people experiencing long COVID, including helping them talk about symptoms with clinicians and family members.
Small delayed benefit seen for loneliness, but larger improvements seen in perceived stress
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
In New England and the Pacific, prevalence tended to be lower, whereas higher prevalence was seen in the South, Midwest and West.
The greatest increase in utilization was seen for veterans aged 85 years and older (6.1 visits) versus those aged 20 to 44 years (4.8 visits).
The findings were clinically significant at three and 12 months versus usual care.
Vaccine effectiveness was 49% at 60 to 119 days after vaccination among tests exhibiting spike gene target failure.
No reason other than mild symptoms was given for almost half of patients at high risk for progression who were not offered treatment.